cimadronate has been researched along with ATLL in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishikawa, C; Kawakami, H; Masuda, M; Matsuda, T; Mori, N; Ohshiro, K; Ohta, T; Okudaira, T; Tanaka, Y; Tomita, M | 1 |
1 other study(ies) available for cimadronate and ATLL
Article | Year |
---|---|
Bisphosphonate incadronate inhibits growth of human T-cell leukaemia virus type I-infected T-cell lines and primary adult T-cell leukaemia cells by interfering with the mevalonate pathway.
Topics: Aged; Animals; Antimetabolites; Apoptosis; Biomarkers; Blotting, Western; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Female; Human T-lymphotropic virus 1; Humans; Inhibitor of Apoptosis Proteins; Jurkat Cells; Leukemia-Lymphoma, Adult T-Cell; Leukemia, T-Cell; Male; Mevalonic Acid; Mice; Mice, SCID; Microtubule-Associated Proteins; Middle Aged; Neoplasm Proteins; Neoplasm Transplantation; Signal Transduction; Survivin; T-Lymphocytes | 2007 |